{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T09:51:23Z","timestamp":1793613083644,"version":"4.5.0"},"reference-count":33,"publisher":"MDPI AG","issue":"1","license":[{"start":{"date-parts":[[2023,1,8]],"date-time":"2023-01-08T00:00:00Z","timestamp":1673136000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Current Oncology"],"abstract":"<jats:p>Online adaptive radiation is a new and exciting modality of treatment for gynecologic cancers. Traditional radiation treatments deliver the same radiation plan to cancers with large margins. Improvements in imaging, technology, and artificial intelligence have made it possible to account for changes between treatments and improve the delivery of radiation. These advances can potentially lead to significant benefits in tumor coverage and normal tissue sparing. Gynecologic cancers can uniquely benefit from this technology due to the significant changes in bladder, bowel, and rectum between treatments as well as the changes in tumors commonly seen between treatments. Preliminary studies have shown that online adaptive radiation can maintain coverage of the tumor while sparing nearby organs. Given these potential benefits, numerous clinical trials are ongoing to investigate the clinical benefits of online adaptive radiotherapy. Despite the benefits, implementation of online adaptive radiotherapy requires significant clinical resources. Additionally, the timing and workflow for online adaptive radiotherapy is being optimized. In this review, we discuss the history and evolution of radiation techniques, the logistics and implementation of online adaptive radiation, and the potential benefits of online adaptive radiotherapy for gynecologic cancers.<\/jats:p>","DOI":"10.3390\/curroncol30010066","type":"journal-article","created":{"date-parts":[[2023,1,9]],"date-time":"2023-01-09T07:28:10Z","timestamp":1673249290000},"page":"865-874","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["The New Kid on the Block: Online Adaptive Radiotherapy in the Treatment of Gynecologic Cancers"],"prefix":"10.3390","volume":"30","author":[{"given":"Allen","family":"Yen","sequence":"first","affiliation":[{"name":"Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chenyang","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Albuquerque","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, University of Texas Southwestern Medical Center, Dallas, TX 75390, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2023,1,8]]},"reference":[{"key":"ref_1","unstructured":"Centers for Disease Control and Prevention (2019). Gynecologic Cancer Incidence, U.S.U.D.B., no 11, Centers for Disease Control and Prevention, US Department of Health and Human Services."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1002\/cam4.187","article-title":"Uterine cervix cancer treatment at Radiumhemmet: 90 years\u2019 experience. Time trends of age, stage, and histopathology distribution","volume":"3","author":"Hellman","year":"2014","journal-title":"Cancer Med."},{"key":"ref_3","unstructured":"Erickson, B., Lim, K., Stewart, J., Donnelly, E., Small, W., Fyles, A., and Milosevic, M. (2011). Adaptive Radiation Therapy for Gynecologic Cancers. Adaptive Radiation Therapy, CRC Press."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1016\/j.clon.2021.06.012","article-title":"Advances in External Beam Radiation Therapy and Brachytherapy for Cervical Cancer","volume":"33","author":"Williamson","year":"2021","journal-title":"Clin. Oncol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"2538","DOI":"10.1200\/JCO.2017.77.4273","article-title":"Patient-Reported Toxicity During Pelvic Intensity-Modulated Radiation Therapy: NRG Oncology\u2013RTOG 1203","volume":"36","author":"Klopp","year":"2018","journal-title":"J. Clin. Oncol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1016\/S0360-3016(00)00771-9","article-title":"Intensity-modulated whole pelvic radiation therapy in patients with gynecologic malignancies","volume":"48","author":"Roeske","year":"2000","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1016\/j.ijrobp.2005.11.007","article-title":"Intensity-modulated radiotherapy for the treatment of vulvar carcinoma: A comparative dosimetric study with early clinical outcome","volume":"64","author":"Beriwal","year":"2006","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1016\/j.ijrobp.2009.10.075","article-title":"Consensus Guidelines for Delineation of Clinical Target Volume for Intensity-Modulated Pelvic Radiotherapy for the Definitive Treatment of Cervix Cancer","volume":"79","author":"Lim","year":"2011","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1088\/0031-9155\/42\/1\/008","article-title":"Adaptive Radiation Therapy","volume":"42","author":"Yan","year":"1997","journal-title":"Phys. Med. Biol."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1016\/j.ijrobp.2011.10.011","article-title":"Individualized nonadaptive and online-adaptive intensity-modulated radiotherapy treatment strategies for cervical cancer patients based on pretreatment acquired variable bladder filling computed tomography scans","volume":"83","author":"Bondar","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/j.ijrobp.2020.10.021","article-title":"Adaptive Radiation Therapy (ART) Strategies and Technical Considerations: A State of the ART Review From NRG Oncology","volume":"109","author":"Lee","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_12","first-page":"48","article-title":"The EMBRACE II study: The outcome and prospect of two decades of evolution within the GEC-ESTRO GYN working group and the EMBRACE studies","volume":"9","author":"Tanderup","year":"2018","journal-title":"Clin. Transl. Radiat. Oncol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.radonc.2016.03.011","article-title":"Image guided brachytherapy in locally advanced cervical cancer: Improved pelvic control and survival in RetroEMBRACE, a multicenter cohort study","volume":"120","author":"Sturdza","year":"2016","journal-title":"Radiother. Oncol."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.ijrobp.2020.08.061","article-title":"NRG Oncology\/RTOG Consensus Guidelines for Delineation of Clinical Target Volume for Intensity Modulated Pelvic Radiation Therapy in Postoperative Treatment of Endometrial and Cervical Cancer: An Update","volume":"109","author":"Small","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1016\/j.ijrobp.2016.02.043","article-title":"Consensus Recommendations for Radiation Therapy Contouring and Treatment of Vulvar Carcinoma","volume":"95","author":"Gaffney","year":"2016","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"e353","DOI":"10.1016\/j.ijrobp.2012.01.023","article-title":"Pelvic normal tissue contouring guidelines for radiation therapy: A Radiation Therapy Oncology Group consensus panel atlas","volume":"83","author":"Gay","year":"2012","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_17","unstructured":"Varian (2020). Ethos Therapy: An Adaptive Intelligence Solution, Varian."},{"key":"ref_18","unstructured":"Elekta (2020). Elekta Unity: Two Worlds, One Future, Elekta."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1055\/s-0028-1083697","article-title":"Magnetic resonance imaging techniques: FMRI, DWI, and PWI","volume":"28","author":"Holdsworth","year":"2008","journal-title":"Semin. Neurol."},{"key":"ref_20","unstructured":"Reflexion (2021). Discover the Reflexion X1, Reflexion."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1186\/s13014-021-01907-1","article-title":"Online MR evaluation of inter- and intra-fraction uterus motions and bladder volume changes during cervical cancer external beam radiotherapy","volume":"16","author":"Li","year":"2021","journal-title":"Radiat. Oncol."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Yen, A., Choi, B., Inam, E., Yeh, A., Lin, M.H., Park, C., Hrycushko, B., Nwachukwu, C., and Albuquerque, K. (2022). Spare the Bowel, Don\u2019t Spoil the Target: Optimal Margin Assessment for Online Cone-Beam Adaptive Radiation Therapy (OnC-ART) of the Cervix. Pract. Radiat. Oncol., in press.","DOI":"10.1016\/j.prro.2022.10.009"},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s13566-018-0366-3","article-title":"Inter-fraction movements of the prostate and pelvic lymph nodes during IGRT","volume":"7","author":"Jonsson","year":"2018","journal-title":"J. Radiat. Oncol."},{"key":"ref_24","unstructured":"(2022, December 01). Daily Adaptive Radiation Therapy an Individualized Approach for Carcinoma of the Cervix, Available online: https:\/\/ClinicalTrials.gov\/show\/NCT05197881."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/j.ijrobp.2009.10.013","article-title":"Online adaptive replanning method for prostate radiotherapy","volume":"77","author":"Ahunbay","year":"2010","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1016\/j.ijrobp.2014.06.046","article-title":"Clinical Implementation of an Online Adaptive Plan-of-the-Day Protocol for Nonrigid Motion Management in Locally Advanced Cervical Cancer IMRT","volume":"90","author":"Heijkoop","year":"2014","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_27","unstructured":"(2022, December 12). Randomized Phase II Study of DCE-MRI-Based Dose Escalation for Poor-Prognosis and Neck Cancer, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT02031250."},{"key":"ref_28","unstructured":"(2022, December 12). Individualized Adaptive De-Escalated Radiotherapy for HPV-Related Oropharynx Cancer, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03416153."},{"key":"ref_29","unstructured":"(2022, December 12). Trial of Magnetic Resonance Imaging Guided Radiotherapy Dose Adaptation in Human Papilloma Virus Positive Oropharyngeal Cancer, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03224000."},{"key":"ref_30","unstructured":"(2022, December 12). Adaptive Radiation Treatment for Head and Neck Cancer (ARTFORCE), Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT01504815."},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.ijrobp.2021.03.047","article-title":"Personalized Ultrafractionated Stereotactic Adaptive Radiotherapy (PULSAR) in Preclinical Models Enhances Single-Agent Immune Checkpoint Blockade","volume":"110","author":"Moore","year":"2021","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1016\/j.ijrobp.2021.08.033","article-title":"Phase I Trial of Stereotactic MRI-Guided Online Adaptive Radiation Therapy (SMART) for the Treatment of Oligometastatic Ovarian Cancer","volume":"112","author":"Henke","year":"2022","journal-title":"Int. J. Radiat. Oncol. Biol. Phys."},{"key":"ref_33","unstructured":"(2022, December 12). Intratreatment FDG-PET during Radiation Therapy for Gynecologic and Gastrointestinal Cancers, Available online: https:\/\/clinicaltrials.gov\/ct2\/show\/NCT03403465."}],"container-title":["Current Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/1\/66\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T18:03:32Z","timestamp":1760119412000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1718-7729\/30\/1\/66"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,1,8]]},"references-count":33,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2023,1]]}},"alternative-id":["curroncol30010066"],"URL":"https:\/\/doi.org\/10.3390\/curroncol30010066","relation":{},"ISSN":["1718-7729"],"issn-type":[{"value":"1718-7729","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023,1,8]]}}}